Skip to main content
SpringerLink
Log in

Clinical experience with sustained-release etodolac: EULAR supplement

Introduction

  • Published:
Rheumatology International Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Lanza FL (1991) Risk factors in antiinflammatory drugs. Compr Ther 17:3–7

    Google Scholar 

  2. Murray MD, Brater DC (1990) Nonsteroidal antiinflammatory drugs. Clin Pharmacol 6:365–397

    Google Scholar 

  3. Samara AM (1987) The therapeutic dilemma: a historical perspective. In: Answering the therapeutic dilemma: redefining NSAID effectiveness and safety. Proceedings of a symposium held November 17, 1986 in conjunction with the IX Pan-American Congress of Rheumatology, Buenos Aires, Argentina. New York, Co Medica, pp 3–5

    Google Scholar 

  4. Bankhead CD (1991) Rheumatoid arthritis. Med World News 32:34–42

    Google Scholar 

Download references

Authors
  1. Graham Hughes
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Hughes, G. Clinical experience with sustained-release etodolac: EULAR supplement. Rheumatol Int 13 (Suppl 2), S1–S2 (1993). https://doi.org/10.1007/BF00290276

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00290276

Search

Navigation